#drug-safety

#drug-safety

The drugmaker Pfizer faces a US lawsuit brought on behalf of women who developed brain tumours, which they say are linked to their use of the company's contraceptive injection Depo-Provera. The class action lawsuit alleges that the US pharmaceutical company failed to warn women and doctors about the increased risk of developing an intracranial meningioma if Depo-Provera, a quarterly injection, is used for more than a year. A court hearing will take place in Pensacola, Florida, on Monday.

One of neurologist Anelyssa D'Abreu's least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer's disease. But it's not quite as bad as it used to be. Today when they ask, "Is there anything we can do?" D'Abreu has a new answer: "Perhaps." Unlike a decade ago, when D'Abreu had little to offer her patients with Alzheimer's, there are now drugs that may impede the disease's progression.

Experts have issued a warning to Mounjaro users over attempts to squeeze extra doses of the weight-loss drug out of prescribed syringes. Under weight loss plans set up through pharmacies, people pay for four weekly doses of the drug injected from a Kwickpen, which should be discarded after use, says the drug manufacturer Eli Lilly. However, some users are drawing out leftover liquid inside the pen - intended for priming before each injection - to create a fifth dose, dubbed the golden dose.

A study has been launched due to reports of serious side effects related to weight loss drugs potentially affecting the pancreas, prompting safety investigations.

Sun Pharma's factory faced severe scrutiny after inspectors found contamination, leading to a ban on exportation to the U.S., highlighting the conflict between safety and drug supply.

To me they were a clean-cut, hardworking couple who left early in the morning and were ambitious. They were a pleasure to be around.

Drug safety experts in the UK warn women using weight-loss jabs should stop if trying for a baby, pregnant or breastfeeding, citing unknown risks to unborn babies.

The HSE warns that a higher dose means a higher risk, particularly when the potency of the product is unclear.